ID   DHB2_HUMAN              Reviewed;         387 AA.
AC   P37059; B2R7T4;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=Estradiol 17-beta-dehydrogenase 2;
DE            EC=1.1.1.62;
DE   AltName: Full=17-beta-hydroxysteroid dehydrogenase type 2;
DE            Short=17-beta-HSD 2;
DE   AltName: Full=20 alpha-hydroxysteroid dehydrogenase;
DE            Short=20-alpha-HSD;
DE   AltName: Full=E2DH;
DE   AltName: Full=Microsomal 17-beta-hydroxysteroid dehydrogenase;
DE   AltName: Full=Short chain dehydrogenase/reductase family 9C member 2;
DE   AltName: Full=Testosterone 17-beta-dehydrogenase;
DE            EC=1.1.1.239;
GN   Name=HSD17B2; Synonyms=EDH17B2, SDR9C2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Prostate;
RX   PubMed=8099587;
RA   Wu L., Einstein M., Geissler W.M., Chan H.K., Elliston K.O.,
RA   Andersson S.;
RT   "Expression cloning and characterization of human 17 beta-
RT   hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20
RT   alpha-hydroxysteroid dehydrogenase activity.";
RL   J. Biol. Chem. 268:12964-12969(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7546291; DOI=10.1089/dna.1995.14.849;
RA   Labrie Y., Durocher F., Lachance Y., Turgeon C., Simard J., Labrie C.,
RA   Labrie F.;
RT   "The human type II 17 beta-hydroxysteroid dehydrogenase gene encodes
RT   two alternatively spliced mRNA species.";
RL   DNA Cell Biol. 14:849-862(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-121.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Capable of catalyzing the interconversion of
CC       testosterone and androstenedione, as well as estradiol and
CC       estrone. Also has 20-alpha-HSD activity. Uses NADH while EDH17B3
CC       uses NADPH.
CC   -!- CATALYTIC ACTIVITY: 17-beta-estradiol + NAD(P)(+) = estrone +
CC       NAD(P)H.
CC   -!- CATALYTIC ACTIVITY: Testosterone + NAD(+) = androstenedione +
CC       NADH.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.21 uM for estradiol {ECO:0000269|PubMed:8099587};
CC         KM=0.39 uM for testosterone {ECO:0000269|PubMed:8099587};
CC         KM=0.31 uM for dihydrotestosterone {ECO:0000269|PubMed:8099587};
CC         KM=0.71 uM for 20-alpha-dihydroprogesterone
CC         {ECO:0000269|PubMed:8099587};
CC         KM=0.78 uM for estrone {ECO:0000269|PubMed:8099587};
CC         KM=2.63 uM for androstenedione {ECO:0000269|PubMed:8099587};
CC         Vmax=38 nmol/min/mg enzyme with estradiol as substrate
CC         {ECO:0000269|PubMed:8099587};
CC         Vmax=45 nmol/min/mg enzyme with testosterone as substrate
CC         {ECO:0000269|PubMed:8099587};
CC         Vmax=38 nmol/min/mg enzyme with dihydrotestosterone as substrate
CC         {ECO:0000269|PubMed:8099587};
CC         Vmax=5.6 nmol/min/mg enzyme with 20-alpha-dihydroprogesterone as
CC         substrate {ECO:0000269|PubMed:8099587};
CC         Vmax=6.6 nmol/min/mg enzyme with estrone as substrate
CC         {ECO:0000269|PubMed:8099587};
CC         Vmax=11.5 nmol/min/mg enzyme with androstenedione as substrate
CC         {ECO:0000269|PubMed:8099587};
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/hsd17b2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L11708; AAA03562.1; -; mRNA.
DR   EMBL; L40802; AAC41917.1; -; Genomic_DNA.
DR   EMBL; L40796; AAC41917.1; JOINED; Genomic_DNA.
DR   EMBL; L40797; AAC41917.1; JOINED; Genomic_DNA.
DR   EMBL; L40798; AAC41917.1; JOINED; Genomic_DNA.
DR   EMBL; L40801; AAC41917.1; JOINED; Genomic_DNA.
DR   EMBL; AY325910; AAP78485.1; -; Genomic_DNA.
DR   EMBL; AK313109; BAG35931.1; -; mRNA.
DR   EMBL; CH471114; EAW95519.1; -; Genomic_DNA.
DR   EMBL; BC009581; AAH09581.1; -; mRNA.
DR   EMBL; BC059170; AAH59170.1; -; mRNA.
DR   CCDS; CCDS10936.1; -.
DR   PIR; A47287; A47287.
DR   RefSeq; NP_002144.1; NM_002153.2.
DR   UniGene; Hs.162795; -.
DR   ProteinModelPortal; P37059; -.
DR   BioGrid; 109527; 2.
DR   IntAct; P37059; 1.
DR   STRING; 9606.ENSP00000199936; -.
DR   BindingDB; P37059; -.
DR   ChEMBL; CHEMBL2789; -.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000001217; -.
DR   iPTMnet; P37059; -.
DR   PhosphoSitePlus; P37059; -.
DR   BioMuta; HSD17B2; -.
DR   DMDM; 544152; -.
DR   MaxQB; P37059; -.
DR   PaxDb; P37059; -.
DR   PeptideAtlas; P37059; -.
DR   PRIDE; P37059; -.
DR   DNASU; 3294; -.
DR   Ensembl; ENST00000199936; ENSP00000199936; ENSG00000086696.
DR   GeneID; 3294; -.
DR   KEGG; hsa:3294; -.
DR   UCSC; uc002fgv.4; human.
DR   CTD; 3294; -.
DR   DisGeNET; 3294; -.
DR   GeneCards; HSD17B2; -.
DR   HGNC; HGNC:5211; HSD17B2.
DR   HPA; HPA021826; -.
DR   HPA; HPA050235; -.
DR   MIM; 109685; gene.
DR   neXtProt; NX_P37059; -.
DR   OpenTargets; ENSG00000086696; -.
DR   PharmGKB; PA29479; -.
DR   eggNOG; KOG1610; Eukaryota.
DR   eggNOG; ENOG410Y7FK; LUCA.
DR   GeneTree; ENSGT00870000136397; -.
DR   HOVERGEN; HBG005482; -.
DR   InParanoid; P37059; -.
DR   KO; K13368; -.
DR   OMA; IAGTSDK; -.
DR   OrthoDB; EOG091G0LMI; -.
DR   PhylomeDB; P37059; -.
DR   TreeFam; TF325617; -.
DR   BRENDA; 1.1.1.62; 2681.
DR   Reactome; R-HSA-193144; Estrogen biosynthesis.
DR   GeneWiki; HSD17B2; -.
DR   GenomeRNAi; 3294; -.
DR   PRO; PR:P37059; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000086696; -.
DR   CleanEx; HS_HSD17B2; -.
DR   ExpressionAtlas; P37059; baseline and differential.
DR   Genevisible; P37059; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0047006; F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; TAS:BHF-UCL.
DR   GO; GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0047035; F:testosterone dehydrogenase (NAD+) activity; IDA:UniProtKB.
DR   GO; GO:0006703; P:estrogen biosynthetic process; TAS:Reactome.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0032526; P:response to retinoic acid; IDA:BHF-UCL.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 2.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   NAD; Oxidoreductase; Polymorphism; Reference proteome; Signal-anchor;
KW   Steroid biosynthesis; Transmembrane; Transmembrane helix.
FT   CHAIN         1    387       Estradiol 17-beta-dehydrogenase 2.
FT                                /FTId=PRO_0000054570.
FT   TRANSMEM      4     24       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   NP_BIND      82    111       NAD. {ECO:0000250}.
FT   ACT_SITE    232    232       {ECO:0000250}.
FT   BINDING     219    219       Substrate. {ECO:0000250}.
FT   VARIANT     121    121       A -> T (in dbSNP:rs8191136).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018852.
SQ   SEQUENCE   387 AA;  42785 MW;  EDE5606EA041042B CRC64;
     MSTFFSDTAW ICLAVPTVLC GTVFCKYKKS SGQLWSWMVC LAGLCAVCLL ILSPFWGLIL
     FSVSCFLMYT YLSGQELLPV DQKAVLVTGG DCGLGHALCK YLDELGFTVF AGVLNENGPG
     AEELRRTCSP RLSVLQMDIT KPVQIKDAYS KVAAMLQDRG LWAVINNAGV LGFPTDGELL
     LMTDYKQCMA VNFFGTVEVT KTFLPLLRKS KGRLVNVSSM GGGAPMERLA SYGSSKAAVT
     MFSSVMRLEL SKWGIKVASI QPGGFLTNIA GTSDKWEKLE KDILDHLPAE VQEDYGQDYI
     LAQRNFLLLI NSLASKDFSP VLRDIQHAIL AKSPFAYYTP GKGAYLWICL AHYLPIGIYD
     YFAKRHFGQD KPMPRALRMP NYKKKAT
//
